Exploratory study on prediction and severity of preeclampsia by L-FABP

prediction and severity of preeclampsia by L-FABP - prediction and severity of preeclampsia by L-FABP

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053653

Enrollment

Registered

2024-02-20

Start date

2022-04-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive disorders of pregnancy

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: After 20 weeks of pregnancy Patients with preeclampsia or risk of developing preeclampsia (cases with any of the following items). *Systolic blood pressure 130 mmHg or more and/or diastolic blood pressure 80mmHg or more *Pregnancy proteinuria (g/Cr > 0.3) *Fetal growth restriction without obvious structural abnormalities *High uterine artery pulsatility index + notch

Exclusion criteria

Exclusion criteria: Fetal malformations chromosomal abnormalities Consent has not been obtained

Design outcomes

Primary

Measure	Time frame
To investigate the difference in serum and urinary L-FABP between HDP group and control group.	—

Countries

Japan

Contacts

Public ContactDaisuke Katsura

Shiga University of Medical Science Department of Obstetrics and Gynecology

katsuo14@belle.shiga-med.ac.jp0775482267

Outcome results